Defining Minimal Clinically Important Difference and Patient Acceptable Symptom State After Isolated Endoscopic Gluteus Medius Repair

最小临床重要差异 美第斯 医学 组内相关 外科 物理疗法 患者报告的结果 生活质量(医疗保健) 随机对照试验 心理测量学 临床心理学 护理部
作者
Kelechi R. Okoroha,Edward C. Beck,Benedict U. Nwachukwu,Kyle N. Kunze,Shane J. Nho
出处
期刊:American Journal of Sports Medicine [SAGE Publishing]
卷期号:47 (13): 3141-3147 被引量:72
标识
DOI:10.1177/0363546519877179
摘要

Background: Endoscopic surgical repair has become a common procedure for treating patients with gluteus medius tears. However, meaningful clinical outcomes after the procedure have not been defined. Purpose: To (1) define the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS) in patients undergoing endoscopic gluteus medius repair and (2) determine correlations between preoperative patient characteristics and achievement of MCID/PASS. Study Design: Case series; Level of evidence, 4. Methods: A retrospective review was performed of prospectively collected data from all patients undergoing primary endoscopic repair of gluteus medius tears between January 2012 and February 2017 with a minimum 2-year follow-up. Patient data collected included patient characteristics, radiographic parameters, preoperative clinical function scores, and postoperative patient-reported outcomes (PROs). Paired t tests were used to compare the differences in 2-year PROs. The MCID and PASS for each PRO were calculated and Spearman coefficient analysis was used to identify correlations between MCID, PASS, and preoperative variables. Results: A total of 60 patients were included in the study. A majority of patients were female (91.7%), with an average age and body mass index of 57.9 ± 9.91 years and 27.6 ± 6.1, respectively. The MCIDs of the Activities of Daily Living (ADL) and Sport-Specific (SS) subscales of the Hip Outcome Score (HOS) and the modified Harris Hip Score (mHHS) were calculated to be 15.02, 14.53, and 14.13, respectively. The PASS scores of HOS-ADL, HOS-SS, and mHHS were calculated to be 81.32, 67.71, and 77.5, respectively. In addition, 76.7% of patients achieved either MCID or PASS postoperatively, with 77.8% and 69.0% reaching at least 1 threshold score for achieving MCID and PASS, respectively, and 48.3% achieving both MCID and PASS. Smoking had a negative and weak association with achieving PASS ( r = −0.271; P = .039). No other patient characteristic variables were found to correlate with achieving MCID or PASS. Conclusion: In patients undergoing endoscopic gluteus medius repair, our study defined MCID and PASS for HOS-ADL, HOS-SS, and mHHS outcome scores. A large percentage of patients (76.7%) achieved meaningful clinical outcomes at 2 years after surgery.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
jsji发布了新的文献求助30
1秒前
1秒前
dustwuw发布了新的文献求助10
2秒前
coolru完成签到 ,获得积分10
2秒前
2秒前
Fluoxetine发布了新的文献求助20
3秒前
3秒前
务实的亦巧完成签到,获得积分10
3秒前
rubo发布了新的文献求助10
4秒前
活力叫兽完成签到,获得积分10
4秒前
4秒前
4秒前
4秒前
李大明星发布了新的文献求助10
4秒前
风中小夏完成签到,获得积分10
4秒前
Hello应助Aquilus采纳,获得20
5秒前
LSW完成签到 ,获得积分10
5秒前
why发布了新的文献求助10
5秒前
英姑应助旧辞采纳,获得10
6秒前
笨笨芾完成签到 ,获得积分20
7秒前
7秒前
JingjingYao发布了新的文献求助10
7秒前
lixiviant完成签到,获得积分10
7秒前
韶糜发布了新的文献求助10
8秒前
8秒前
8秒前
飘逸问晴完成签到,获得积分10
9秒前
10秒前
10秒前
10秒前
TIDUS发布了新的文献求助10
11秒前
英俊夜云完成签到,获得积分10
12秒前
12秒前
v0id应助含蓄诗槐采纳,获得10
13秒前
14秒前
ikun完成签到,获得积分10
16秒前
16秒前
18秒前
18秒前
学不明白完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Markov Chain Monte Carlo 5000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Evidence Summary. Injection (subcutaneous):op- timal administration 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7493418
求助须知:如何正确求助?哪些是违规求助? 9084933
关于积分的说明 19375562
捐赠科研通 7105402
什么是DOI,文献DOI怎么找? 3249566
关于科研通互助平台的介绍 2418996
邀请新用户注册赠送积分活动 2235188